A new era in the treatment of urothelial carcinoma

被引：0
|
作者：
Faltas, Bishoy [1 ,2 ]
机构：
[1] Weill Cornell Med, Dept Hematol & Oncol, New York, NY 10065 USA
[2] Weill Cornell Med, Dept Cell & Dev Biol, New York, NY 10065 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2023年 / 41卷 / 10期
关键词：
Urothelial carcinoma; FGFR3; inhibition; Antibody-drug conjugates (ADCs); Immunotherapy; ANTIBODY-DRUG CONJUGATE; OPEN-LABEL; CANCER; MULTICENTER;
D O I：
10.1016/j.urolonc.2023.08.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The advances in targeted therapies, immunotherapy, and the recent emergence of antibody-drug conjugates (ADCs) herald a potential paradigm shift in treating patients with metastatic urothelial cancer. Yet, there are inherent challenges in utilizing these therapies, including the management of treatment-related toxicities. In this special Urologic Oncology: Seminars and Original Investigations issue, we review the latest developments and discuss insights into future research needs. (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码：395 / 397
页数：3
相关论文
共 50 条
  • [21] Genomics and Immunomics in the Treatment of Urothelial Carcinoma
    Mollica, Veronica
    Massari, Francesco
    Rizzo, Alessandro
    Ferrara, Roberto
    Menta, Arjun K.
    Adashek, Jacob J.
    CURRENT ONCOLOGY, 2022, 29 (05) : 3499 - 3518
  • [22] A New Era in Salivary Gland Carcinoma Treatment: A Case Report
    Mendonca, Joana C.
    Barbosa, Ana
    Vieira, Claudia
    Dinis, Jose
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
  • [23] Immunotherapy for the treatment of advanced nasopharyngeal carcinoma: a promising new era
    Wang, Shaoli
    Chen, Siying
    Zhong, Qionglei
    Liu, Yan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (05) : 2071 - 2079
  • [24] Immunotherapy for the treatment of advanced nasopharyngeal carcinoma: a promising new era
    Shaoli Wang
    Siying Chen
    Qionglei Zhong
    Yan Liu
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2071 - 2079
  • [25] New targeted agents for urothelial carcinoma
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2019, 16 : 591 - 591
  • [26] New targeted agents for urothelial carcinoma
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (10) : 591 - 591
  • [27] Treatment of squamous cell carcinoma of the anal canal (SCCA): a new era?
    Gardini, A. Casadei
    Valgiusti, M.
    Passardi, A.
    Frassineti, G. L.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2620 - 2620
  • [28] Revolutionizing hepatocellular carcinoma treatment: the advent of a new era of adjuvant therapy
    Lim, Joshua Sheng Hao
    Shelat, Vishal G.
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (05)
  • [29] Check point inhibitors a new era in renal cell carcinoma treatment
    Mohamed Alsharedi
    Heather Katz
    Medical Oncology, 2018, 35
  • [30] Check point inhibitors a new era in renal cell carcinoma treatment
    Alsharedi, Mohamed
    Katz, Heather
    MEDICAL ONCOLOGY, 2018, 35 (06)
12345